Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and potential efficacy of adding ZEN003694 to standard chemotherapy for adults and pediatric patients (12-17…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZEN003694

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced NUT Carcinoma, Metastatic NUT Carcinoma | Phase 1, Phase 2 | Status: RECRUITING